×
News Home

Is Trulieve Cannabis Corp (TCNNF) a Laggard in the Healthcare Sector?

Tuesday, July 20, 2021 02:32 PM | InvestorsObserver Analysts
Is Trulieve Cannabis Corp (TCNNF) a Laggard in the Healthcare Sector?

Trulieve Cannabis Corp (72) is near the middle in its sector according to InvestorsObserver. TCNNF gets an overall rating of 72. That means it scores higher than 72% of stocks. Trulieve Cannabis Corp gets a 47 rank in the Healthcare sector. Healthcare is number 8 out of 11 sectors.

Overall Score - 72
TCNNF has an Overall Score of 72. Find out what this means to you and get the rest of the rankings on TCNNF!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 72 would rank higher than 72 percent of all stocks. Not only are these scores easy to understand, but it is easy to compare stocks to each other. You can find the best stock in healthcare or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Trulieve Cannabis Corp Stock Today?

Trulieve Cannabis Corp (TCNNF) stock is trading at $33.94 as of 1:58 PM on Tuesday, Jul 20, an increase of $0.02, or 0.06% from the previous closing price of $33.92. Volume today is below average. So far 152,236 shares have traded compared to average volume of 300,777 shares. The stock has traded between $33.77 and $34.64 so far today. Click Here to get the full Stock Report for Trulieve Cannabis Corp stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App